S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
BREAKING: The truth about war with China (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Disney, DeSantis legal fights ratchet up as company demands documents from Florida governor
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
BREAKING: The truth about war with China (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Disney, DeSantis legal fights ratchet up as company demands documents from Florida governor
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
BREAKING: The truth about war with China (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Disney, DeSantis legal fights ratchet up as company demands documents from Florida governor
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
BREAKING: The truth about war with China (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Disney, DeSantis legal fights ratchet up as company demands documents from Florida governor
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
NASDAQ:ABIO

ARCA biopharma (ABIO) Stock Forecast, Price & News

$2.01
0.00 (0.00%)
(As of 09/29/2023 ET)
Compare
Today's Range
$2.01
$2.02
50-Day Range
$2.00
$2.07
52-Week Range
$1.85
$2.70
Volume
18,760 shs
Average Volume
22,521 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ABIO stock logo

About ARCA biopharma (NASDAQ:ABIO) Stock

ARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. It is also developing Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. The company was founded in 2004 and is headquartered in Westminster, Colorado.

ABIO Price History

ABIO Stock News Headlines

3 Words and a 3,000% Return
In October 2013, a scientist wrote 3 words on a piece of paper. They were simple words. A fiveyear-old could say them. But these three words could deliver you a 3,000% return in 2023 >>>
ABIO - ARCA biopharma, Inc.
3 Words and a 3,000% Return
In October 2013, a scientist wrote 3 words on a piece of paper. They were simple words. A fiveyear-old could say them. But these three words could deliver you a 3,000% return in 2023 >>>
See More Headlines
Receive ABIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter.

ABIO Company Calendar

Last Earnings
7/21/2023
Today
10/01/2023
Next Earnings (Estimated)
10/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ABIO
Employees
5
Year Founded
N/A

Profitability

Net Income
$-9,930,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.89 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.30
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Michael R. Bristow M.D. (Age 78)
    Ph.D., Co-Founder, Pres, CEO & Director
    Comp: $358.8k
  • Mr. Thomas A. Keuer (Age 64)
    Chief Operating Officer
    Comp: $360.59k
  • Mr. C. Jeffrey Dekker CPA (Age 58)
    Chief Financial Officer













ABIO Stock - Frequently Asked Questions

How have ABIO shares performed in 2023?

ARCA biopharma's stock was trading at $2.37 at the beginning of 2023. Since then, ABIO stock has decreased by 15.2% and is now trading at $2.01.
View the best growth stocks for 2023 here
.

Are investors shorting ARCA biopharma?

ARCA biopharma saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 265,000 shares, an increase of 9.5% from the August 31st total of 242,000 shares. Based on an average daily trading volume, of 20,600 shares, the short-interest ratio is currently 12.9 days. Currently, 1.9% of the company's stock are sold short.
View ARCA biopharma's Short Interest
.

When is ARCA biopharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, October 27th 2023.
View our ABIO earnings forecast
.

How were ARCA biopharma's earnings last quarter?

ARCA biopharma, Inc. (NASDAQ:ABIO) released its quarterly earnings data on Friday, July, 21st. The biopharmaceutical company reported ($0.10) earnings per share (EPS) for the quarter.

What is Michael R. Bristow's approval rating as ARCA biopharma's CEO?

1 employees have rated ARCA biopharma Chief Executive Officer Michael R. Bristow on Glassdoor.com. Michael R. Bristow has an approval rating of 100% among the company's employees. This puts Michael R. Bristow in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of ARCA biopharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ARCA biopharma investors own include Aurora Cannabis (ACBFF), MannKind (MNKD), Bausch Health Companies (BHC), Biocept (BIOC), Novavax (NVAX), AVEO Pharmaceuticals (AVEO), Gilead Sciences (GILD), iBio (IBIO), Nabriva Therapeutics (NBRV) and Synergy Pharmaceuticals (SGYP).

What is ARCA biopharma's stock symbol?

ARCA biopharma trades on the NASDAQ under the ticker symbol "ABIO."

How do I buy shares of ARCA biopharma?

Shares of ABIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ARCA biopharma's stock price today?

One share of ABIO stock can currently be purchased for approximately $2.01.

How can I contact ARCA biopharma?

ARCA biopharma's mailing address is 11080 CIRCLEPOINT ROAD SUITE 140, WESTMINSTER CO, 80020. The official website for the company is arcabio.com. The biopharmaceutical company can be reached via phone at (720) 940-2100, via email at derek.cole@arcabio.com, or via fax at 720-208-9261.

This page (NASDAQ:ABIO) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -